BL
ABMD

Balentine LLC’s Abiomed Inc ABMD Stock Holding History

Balentine LLC’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3
Closed -$1K – 899
2020
Q2 		$1K Buy
+3
New +$602 ﹤0.01% 918
2020
Q1 		– Sell
-11
Closed -$2K – 708
2019
Q4 		$2K Buy
11
+3
+38% +$556 ﹤0.01% 549
2019
Q3 		$1K Buy
+8
New +$1.73K ﹤0.01% 727
2018
Q1 		– Sell
-1,000
Closed -$187K – 558
2017
Q4 		$187K Sell
1,000
-500
-33% -$93.4K 0.01% 129
2017
Q3 		$253K Buy
+1,500
New +$227K 0.02% 97

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balentine LLC's ABMD Position: Q3 2020 in Review

Balentine LLC sold out of Abiomed Inc (ABMD) in Q3 2020, closing a stake of 3 shares — an estimated $1K sold.

Balentine LLC first reported a position in ABMD in Q3 2017 and held it in 5 quarters. The position peaked at $253K in Q3 2017. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2020.

  • Balentine LLC reported no remaining Abiomed Inc position as of Q3 2020 after selling out during the quarter.
  • Balentine LLC sold 3 Abiomed Inc shares in Q3 2020, an estimated $1K.
  • Balentine LLC first reported a position in Abiomed Inc in Q3 2017 and held it in 5 quarters.
  • Balentine LLC's Abiomed Inc position peaked at $253K in Q3 2017.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2020.

Based on Balentine LLC's 13F filing for Q3 2020, filed 2 Nov 2020.